m+Medelevator.RU
← Поиск публикаций
Cureus · 2026

Evaluating the Impact of Insurer-Sponsored Health Coaching on Hospitalization and Costs in India: A Retrospective Cohort Study.

Название и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Karajgi G, Patidar R, Aggarwal K, Verma K

Аннотация

Health coaching programs are emerging as a promising intervention to improve disease management and reduce healthcare costs, particularly in the context of insurer-sponsored wellness initiatives. While such programs have shown positive outcomes in Western healthcare settings, their effectiveness in India remains underexplored. This study examines the impact of a health coaching program implemented by a prominent Indian health insurer (Aditya Birla Health Insurance), focusing on hospitalization rates and claims paid among high-risk policyholders. To assess the intervention's effectiveness, a retrospective analysis was conducted on participants enrolled in the ABHI-Zyla Health Coaching Program from April 2023 to March 2024. Analyzing patient engagement data for 29,463 patients, we found that higher participation in health coaching, measured by the number of interventions made, was associated with lower total claims paid for preventable conditions. Regression results indicate that this relationship is stronger for females and those with a higher number of resolved symptoms as a result of the interventions. These findings suggest that structured health coaching can play a vital role in reducing hospitalization rates and healthcare costs. By providing empirical evidence on the benefits of insurer-led coaching programs, this study offers actionable insights for insurers, policymakers, and healthcare providers. Strengthening such initiatives can contribute to a shift toward proactive disease management, ultimately addressing the growing burden of non-communicable diseases in India, as well as saving claim costs for insurers.

Перевод полного текста: Перевод в очереди

Читать найденный полный текст

This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Introduction

India is witnessing a rapid rise in non-communicable diseases (NCDs), which now account for more than 60% of total deaths. Conditions such as cardiovascular disease, diabetes, and hypertension are placing an immense burden on the healthcare system. This growing prevalence of chronic illnesses is closely linked to rapid urbanization, sedentary lifestyles, poor dietary habits, and an aging population. Data show that the proportion of cardiovascular disease-related deaths nearly doubled from 15% in 1990 to 28% in 2016, marking an 87% relative increase [ 1 ]. Much of this escalation can be attributed to preventable complications arising from inadequate disease management, delayed interventions, and lifestyle-related risk factors. India’s constrained public health ecosystem and limited follow-up care further worsen the situation, contributing to higher hospitalization rates - the proportion of users who experienced at least one hospitalization during a specified observation period - and increased healthcare expenditure [ 2 ].

Because a significant portion of healthcare expenses in India are paid out-of-pocket, many households experience financial strain or fall into poverty when dealing with chronic illnesses [ 3 ]. This financial vulnerability has prompted insurers such as Aditya Birla Health Insurance (ABHI) to explore proactive healthcare strategies aimed at improving patient outcomes while containing costs. Instead of relying solely on reactive medical care, insurers are increasingly turning toward preventive interventions as a means to reduce claims and enhance policyholder well-being.

Despite the growing burden of chronic disease in India, health insurance frameworks have historically adopted a reactive, curative stance, primarily covering hospitalization and treatment costs rather than prevention or disease management. While global evidence demonstrates that health coaching interventions improve clinical outcomes in diabetes, hypertension, and related conditions (reducing HbA1c, blood pressure, and cholesterol levels) while lowering healthcare utilization and costs, such proactive, integrated disease management models remain underexplored within India's insurance landscape. Recent systematic reviews highlight that health coaching significantly enhances quality of life and self-efficacy in chronic illness care, and telemedicine-enabled coaching strategies have proven equally or more effective than in-person consultations in reducing HbA1c by 0.31-0.44% compared to standard care alone. However, most published evidence emanates from developed health systems with different socioeconomic, cultural, and operational contexts. The Indian health insurance sector, despite schemes like Ayushman Bharat and earlier programs such as Rashtriya Swasthya Bima Yojana, has focused primarily on financial protection and hospitalization coverage, with limited empirical evidence on the effectiveness of structured health coaching programs tailored to high-risk, insured populations. This gap is particularly significant given India's escalating diabetes and hypertension prevalence and the cost-containment imperatives facing private insurers.

In recent years, progressive health insurers like ABHI have introduced wellness programs designed to encourage healthy behavior and improve overall health outcomes. However, most initiatives have traditionally centered around physical activity tracking, health screenings, and reward-based incentives [ 4 ]. Health coaching - although not uniformly defined in literature - has emerged as a patient-centered approach grounded in established behavior change models such as the Transtheoretical Model, Social Cognitive Theory, and Motivational Interviewing [ 5 ]. Typically, health coaching incorporates structured goal setting, personalized guidance, self-monitoring, and accountability, all aimed at sustaining long-term improvements in health behaviors [ 6 ].

While the benefits of insurer-sponsored health coaching programs have been documented in Western countries, including reductions in weight, improvements in glycemic control, and smoking cessation [ 7 ], their effectiveness in the Indian context remains underexplored. Early evidence from lifestyle interventions in India suggests promising potential for improving chronic disease management [ 8 ], yet systematic evaluations of insurer-led health coaching and its influence on hospitalization rates and claims remain limited.

ABHI is among the first insurers in India to launch a structured risk and disease management program targeting high-risk policyholders, initiated around 2020 as part of the broader “Health-First” model and scaled substantially by FY25. Engagement in this program refers to a policyholder’s active participation in health coaching, defined as successful completion of onboarding and, where applicable, continued interaction through scheduled care calls and chat communication, while onboarding denotes the user’s status with respect to informed consent and initiation of the health coaching program, operationalized as successful completion of the initial onboarding call. Through the Chronic Care Management Program and a broader wellness ecosystem, including the WellBeing Score™, HealthReturns™, Healthy Heart Score™, and Active Dayz™, policyholders with chronic conditions such as diabetes, hypertension, hyperlipidemia, and asthma received personalized health coaching from day 1, along with coverage for outpatient diagnostics, consultations, and pharmacy expenses. By FY25, more than one lakh customers had received health coaching services, and another 1.6 lakh had benefited from additional clinical interventions, with 81% of engaged customers showing measurable improvements in key health indicators such as HbA1c, cholesterol, blood pressure, and blood sugar levels. These outcomes illustrate ABHI’s transition from a reactive insurance model to one that proactively manages disease burden and incentivizes long-term healthy behavior, further reinforced by ABHI’s partnership with Zyla Health in 2022 to scale health coaching for specific cohorts of high-risk members.

The present research, conducted using real-world evidence provided by ABHI in collaboration with Zyla Health, seeks to generate actionable insights into how insurers can optimize the design and delivery of health coaching programs. The findings have the potential to inform strategic decisions regarding investments in preventive health initiatives and support a broader shift toward proactive disease management in India’s insurance landscape. Moreover, as India continues to strengthen its public health infrastructure, the insights from this study may guide policymakers in conceptualizing scalable interventions to curb the rising burden of NCDs [ 9 ].

The primary objective of this study is to evaluate the impact of an insurer-sponsored health coaching program on total claims paid among high-risk policyholders. Specifically, the analysis will examine how demographic factors such as age and gender influence program adherence and claim outcomes. We expect that higher levels of engagement with coaching sessions will be associated with improved health outcomes and lower hospitalization claims. Additionally, we anticipate that improvements in symptoms may mediate the relationship between coaching engagement and healthcare costs. By exploring these questions, this study aims to contribute evidence-based guidance for insurers, healthcare providers, and policymakers seeking to design more effective preventive health strategies within India’s evolving healthcare ecosystem.

Research questions

This study examines the effect of insurer-led health coaching on healthcare use and costs among high-risk policyholders and addresses the following questions:

What is the impact of insurer-sponsored health coaching on hospitalization rates and claims paid among high-risk policyholders in India?

How do demographic factors (age, gender) influence program adherence and hospitalization outcomes?

Is higher engagement with coaching sessions (measured by number of calls) associated with improved health outcomes and lower hospitalization rates?

Do symptom improvements mediate the relationship between coaching engagement and healthcare costs?

How does gender moderate the relationship between coaching call frequency and total claims paid?

How does symptom resolution (both complete and partial) moderate the relationship between coaching calls and healthcare expenditure?

Materials and methods

ABHI offers a comprehensive health coaching program designed to support high-risk policyholders who are living with chronic conditions such as dyslipidemia, hypertension, type 2 diabetes, and obesity. The program seeks to promote sustained health behavior change and reduce the likelihood of complications that frequently lead to hospitalization. To ensure broad awareness, ABHI promotes the program through its agent network as well as its digital platforms, allowing beneficiaries across demographic groups to learn about and access the service. The initiative is jointly developed and overseen by ABHI and Zyla Health, enabling the integration of clinical expertise with technology-driven engagement to deliver personalized and structured interventions. High-risk individuals are identified using underwriting data, historical claims information, and findings from annual health check-ups. Once flagged, trained representatives reach out by phone to explain the program and onboard eligible members.

After enrollment, patients enter a structured nine-month coaching journey consisting of six scheduled sessions with a qualified clinical nutritionist. Reminder notifications are sent one day before and on the day of each appointment to promote adherence. The first coaching session, which is conducted in the patient’s regional language, acts as a detailed intake assessment. During this call, the health coach captures information on the patient’s medications, presenting symptoms, coexisting conditions, laboratory results, previous surgeries, family health history, lifestyle habits, and daily routines. All details are systematically documented in ABHI’s in-house electronic medical record (EMR) system to ensure consistency and continuity in follow-up interactions. Drawing from this assessment, the coach sets individualized health goals with the patient and formulates a customized nutrition plan that reflects the patient’s medical needs, demographic profile, and food preferences. Follow-up coaching sessions take place approximately every six weeks and are focused on reviewing adherence, monitoring changes in symptoms, and reinforcing motivation to maintain lifestyle improvements. Medical questions raised during these sessions are addressed by a general physician, while issues such as body pain are escalated to a physiotherapist for further guidance.

Alongside these scheduled sessions, the program incorporates personalized digital engagement delivered through ABHI’s omni-channel platforms. Patients receive targeted nudges and reminders to track specific health parameters, along with curated educational content tailored to their primary chronic condition. Additional support is available through ABHI’s integrated mobile application, where patients can submit queries at any time, ensuring continuous guidance beyond formal coaching sessions. This combination of structured coaching, medical oversight, and technology-based reinforcement supports long-term engagement and strengthens disease management outcomes.

To evaluate the effectiveness of this intervention, we conducted a retrospective analysis of individuals enrolled in the ABHI-Zyla Health Coaching Program between April 2023 and March 2024. The study draws from two primary data sources. The first includes information supplied by ABHI that is available at the time of underwriting, along with claims data, results from annual health assessments, and any newly declared health information submitted during the policy period. This information is securely transferred to the coaching team through system integrations and data-sharing mechanisms that comply with applicable security regulations. The second source consists of health-related data collected during the coaching journey itself, gathered through regular coach interactions and digital touchpoints within ABHI’s app. All data are coded using standardized medical classifications such as ICD-10 and LOINC to ensure accuracy, consistency, and analytical reliability.

Participants were eligible for inclusion in the study if they were registered members of ABHI who had been identified as high-risk for health complications associated with chronic conditions. Only individuals who had at least one diagnosis of obesity, type 2 diabetes, dyslipidemia, or hypertension were considered, and they must have been enrolled in the ABHI-Zyla Health Coaching Program between April 2023 and March 2024. Participants were excluded if they had incomplete or missing baseline data required for analysis, were diagnosed primarily with acute or non-chronic conditions beyond the scope of the coaching program, withdrew consent for the use of their data, or had records that could not be reliably linked across the ABHI and Zyla data systems. The final analytical sample comprised 29,463 patients who had at least one diagnosis of obesity, type 2 diabetes, dyslipidemia, or hypertension.

Symptoms were recorded using the International Classification of Diseases, Tenth Revision (ICD-10) framework (Appendix). At enrollment, symptoms were identified through a structured telephonic interaction conducted by a trained health coach and coded into ICD-10 based on patient-reported complaints and clinician-approved mapping protocols embedded within Zyla Health’s electronic medical record system. During each follow-up interaction, the health coach systematically assessed the status of previously recorded symptoms using a standardized questionnaire. Symptom status was determined based on patient self-report during the phone consultation and categorized into one of four predefined outcome states: same as before, better than before, completely resolved, or worse than before. The categorization criteria were as follows: “completely resolved” indicated that the patient reported complete absence of the symptom since the prior interaction; “better than before” indicated a clear subjective improvement in symptom frequency, intensity, or functional impact, but with persistence of the symptom to some degree; “same as before” indicated no meaningful change in the symptom as perceived by the patient; and “worse than before” indicated an increase in symptom severity, frequency, or negative impact on daily activities compared to the prior assessment. Symptom resolution and improvement status were therefore based on patient self-report rather than direct clinical examination. Health coaches were trained to use consistent probing questions and documentation standards to minimize inter-observer variability, and symptom status was recorded in the electronic medical record.

Our measurement strategy focused on capturing the key elements of program engagement and health progression. Onboarded status was recorded as a binary indicator reflecting whether a patient consented to participate in the coaching program and actively began using the service. Engagement was further assessed through the number of successful calls completed with the health coach following onboarding. Health status at baseline was captured through the total number of symptoms reported during the initial assessment call. Measures of improvement included the number of symptoms that had fully resolved and the number that had improved but not completely resolved, both documented in the EMR system. Demographic attributes such as age and gender were included to account for their potential influence on engagement and outcomes.

The study’s dependent variables focused on healthcare utilization following the intervention. The total number of preventable claims post-intervention captured claims linked to complications from chronic conditions that could potentially be avoided with better disease management, excluding unavoidable medical events such as those involving trauma or maternity care. The total claim paid amount for such preventable claims captured the financial impact on the insurer. When examined together, these variables offered a comprehensive understanding of how program participation and symptom changes relate to healthcare use and cost.

The analysis aimed to address three main objectives. First, we examined correlations among the independent variables, demographic characteristics, and the two key dependent outcomes. Second, we evaluated the direct effects of age, gender, onboarding status, engagement (measured through number of calls), and symptom-related indicators on the total claim paid amount for preventable conditions after the intervention. Finally, given that the number of coaching calls represents the core mechanism through which patients receive support, we tested whether its influence on claim costs was moderated by key variables such as gender and symptom improvements, including both complete resolution and partial improvement. Together, these analyses provide deeper insights into the pathways through which health coaching may influence patient outcomes and healthcare expenditures.

Results

Prior to analysis, data completeness was assessed across all variables. Of the 38,250 eligible participants, 8,787 (22.9%) were excluded due to missing outcome data (total claims post-intervention) or incomplete baseline demographic information. The final analytical sample comprised 29,463 individuals (77.1%). Missing data patterns were examined; data were found to be missing completely at random (MCAR) as assessed using Little's MCAR test (χ² = 124.5, p = 0.053). Given the large sample size and assumption of MCAR, complete-case analysis was deemed appropriate without employing multiple imputation.

Descriptive statistics (means, standard deviations, and frequency distributions) for all variables were computed. Pearson correlations were calculated to assess bivariate associations among continuous variables and point-biserial correlations for categorical-continuous relationships. Normality of the dependent variable (total claim paid amount) was assessed using Q-Q plots and the Shapiro-Wilk test. Given significant departures from normality (W = 0.823, p < 0.001), we log-transformed the outcome variable to satisfy regression assumptions, while unstandardized estimates were back-transformed for interpretation.

The following three hierarchical ordinary least squares (OLS) regression models were fitted with total claim paid amount for preventable claims (post-intervention) as the dependent variable:

Model 1 (baseline): age, gender, and onboarded status as predictors

Model 2: added engagement (number of calls) and symptom-related variables

Model 3: tested moderation effects by including interaction terms (number of calls × gender; number of calls × symptoms resolved; number of calls × symptoms better)

Analyses were conducted in R (version 4.3.1) using the car, lmtest, and interactions packages. All statistical tests were two-tailed with α = 0.05.

Table 1 presents the mean values, standard deviations, and correlations (unadjusted) among the study variables for 29,463 patients (77.1%). The average age of patients in the sample was 42.1 years, and 10,607 (36%) of the participants were female. Age demonstrated a positive and significant correlation with all other variables in the study, indicating that older patients tended to engage more with the program and reported a greater number of symptoms, as well as more symptoms that had improved or resolved. Consistent with this pattern, we found that the average age of onboarded patients (43.4 years; N = 15,077) was significantly higher than that of patients who did not onboard (40.8 years; N = 14,386), a difference that was statistically significant (p < 0.001).

Table 1
Means, SDs, and correlations among the study variable Gender – 0 as male and 1 as female. Onboarding status – 0 as not onboarded and 1 as onboarded. #Total claim paid amount for preventable claims post-intervention (N = 29,463). *p < 0.05. SD, standard deviation

S. No.VariablesMeanSD12345678
1.Age42.110.3--------
2.Gender0.360.480.07*-------
3.Onboarded status0.510.500.12*-0.07*------
4.No. of calls1.121.450.10*-0.07*0.75*-----
5.No. of symptoms0.691.380.07*0.07*0.48*0.50*----
6.No. of symptoms better0.120.470.04*0.04*0.24*0.35*0.52*---
7.No. of symptoms resolved0.140.530.02*0.010.26*0.44*0.55*0.21*--
8.No. of preventable claims0.010.090.04*0.000.07*0.000.000.000.00-
9.Total claim #701.113969.50.04*-0.01*0.05*0.01-0.010.00-0.010.64*

Gender was also significantly associated with several program engagement and health outcome indicators. Female participants reported a higher number of symptoms compared to male participants but made fewer calls to the health coach. The proportion of females in the not-onboarded group (N=11,638; 39.5%) was significantly higher than in the onboarded group (N=9,664; 32.8%), suggesting lower levels of uptake among women (p < 0.001). Onboarding status itself was found to be higher among male participants and was positively correlated with the total claims paid amount. This association is likely driven by selection bias, as individuals with more severe health conditions - who naturally incur higher claim amounts - are more likely to opt into the coaching program. Importantly, the number of coaching calls made by patients was positively correlated with the number of symptoms reported initially, as well as the number of symptoms that improved or resolved during the course of the program, indicating that higher engagement is associated with better health progress.

In terms of overall program engagement, 15,085 (51.2%) of patients with at least one chronic diagnosis onboarded into the program by providing consent during the outreach call. Among those who onboarded, only 4,963 (32.9%) were female, echoing earlier gender-based differences in participation. Nearly half of the full sample (7,497; 49.7%) made at least one call with the health coach. For onboarded members, the average number of calls was 2.2, with a median of two calls, suggesting moderate engagement levels across the cohort. The mean number of claims post-enrollment was 1.02 in engaged users versus 1.48 in non-engaged users (p<0.05), representing a 31% reduction in healthcare utilization events among those actively participating in the coaching program.

Table 2 summarizes the regression analyses (adjusted) conducted to identify factors influencing the total claim paid amount for preventable claims following the intervention. We also tested moderation effects of gender, number of symptoms resolved, and number of symptoms improved on the relationship between the number of calls and total claims paid. Age emerged as a significant predictor of claim amounts, with older patients incurring higher total claims compared to younger individuals (b = 0.03; p < 0.01). After controlling for age and gender, the number of calls showed a significant negative association with total preventable claim amounts (b = -0.08; p < 0.01), indicating that increased engagement through coaching calls is linked to reduced healthcare costs.

Table 2
Results of regression analysis Note: N = 29,463 SE, standard error; b, standardized estimate; no. of calls, number of calls; no. of symptoms, number of symptoms; no. of symptoms better, number of symptoms better; no. of symptoms resolved, number of symptoms resolved *p < 0.05; **p < 0.01.

Total claim paid amount for preventable claims post-intervention
Model 1Model 2Model 3
Predictors(1)bSEbSEbSE
Intercept-0.11**0.01-0.10**0.01-0.11**0.01
Age0.03**0.010.03**0.010.03**0.01
Gender-0.010.01-0.010.01-0.010.01
Onboarded status0.21**0.000.21**0.020.21**0.02
No. of calls-0.08**0.01-0.08**0.00-0.08**0.01
No. of symptoms-0.00-0.01-0.01
No. of symptoms better-----0.020.01
No. of symptoms resolved---0.010.01--
No. of calls * gender-0.02*0.01----
No. of calls * no. of symptoms resolved--0.01*0.00--
No. of calls * no. of symptoms better----0.02*0.01

Further insights from the unstandardized regression coefficients in Table 3 reveal that each additional coaching call is associated with a reduction of INR 667.99 in total claim amounts, holding all other variables constant. When accounting for the average cost of delivering the intervention, we found that every rupee invested in coaching calls yielded savings of approximately 1.72 rupees in claim payments. The analysis was conducted on a sample of 29,463 individuals with at least one of the four chronic conditions under focus, among whom 155 preventable hospitalization claims were recorded in the post-intervention period.

Table 3
Results of regression analysis (unstandardized) Note: N = 29,463 SE, standard error; b, unstandardized estimate *p < 0.01.

Total claim paid amount for preventable claims post -intervention
PredictorsbSE
Intercept-1609.25*344.33
Age40.82*7.89
Gender-134.95171.26
Onboarded status3052.78*251.54
No. of calls-667.99*87.82
No. of symptoms-257.457*69.96

Gender significantly moderated the relationship between the number of calls and the total claim paid amount (b = -0.02; p < 0.05). Specifically, the negative association between coaching calls and claim amounts was stronger for female patients. Conditional effects computed at high (+1 SD) and low (-1 SD) levels of gender, along with simple slope tests [ 10 ], revealed that increases in the number of calls resulted in a significantly greater reduction in claim amounts for women compared to men, as illustrated in Figure 1 .

Figure 1 The interaction effects of gender on the relationship between no. of calls and total claims paid amount *Total claims: total value (in Indian rupees) of preventable claim…
Figure 1 The interaction effects of gender on the relationship between no. of calls and total claims paid amount *Total claims: total value (in Indian rupees) of preventable claims paid post-intervention *nCalls: number of successful coach calls to a user *Low gender: males; high gender: females

The number of symptoms resolved also moderated the relationship between call frequency and claim amounts (b = 0.01; p < 0.05). Patients who experienced a higher number of resolved symptoms benefited more from increased engagement, showing a stronger negative relationship between calls and claim amounts. As shown in Figure 2 , individuals with a greater number of resolved symptoms incurred lower claim amounts across both low and high levels of call frequency. Among the 4,272 unique users who showed symptom improvement or resolution, a total of 7,626 symptoms were documented as improved or resolved.

Figure 2 The interaction effects of no. of symptoms resolved on the relationship between no. of calls and total claims paid amount *Total claims: total value (in Indian rupees) of…
Figure 2 The interaction effects of no. of symptoms resolved on the relationship between no. of calls and total claims paid amount *Total claims: total value (in Indian rupees) of preventable claims paid post-intervention *nCalls: number of successful coach calls to a user *symresolved: symptoms resolved after intervention

Finally, the number of symptoms reported as "better" (but not fully resolved) significantly moderated the relationship between the number of calls and total claims (b = 0.02; p < 0.05). As illustrated in Figure 3 , patients with fewer partially improved symptoms demonstrated a steeper reduction in claim amounts as call frequency increased. Nonetheless, individuals with a higher number of improved symptoms consistently reported lower claim amounts regardless of whether they made relatively few or many calls.

Figure 3 The interaction effects of no. of symptoms better on the relationship between no. of calls and total claims paid amount *Total claims: total value (in Indian rupees) of p…
Figure 3 The interaction effects of no. of symptoms better on the relationship between no. of calls and total claims paid amount *Total claims: total value (in Indian rupees) of preventable claims paid post-intervention *nCalls: number of successful coach calls to a user *symbetter: symptoms better after intervention

Discussion

The findings of this study provide valuable insights into the association between ABHI-sponsored health coaching programs and healthcare costs among high-risk policyholders in India. The results highlight the observed relationship between patient engagement in such programs and health outcomes, with a notable correlation between the number of coaching calls and reported improvements in health status. These findings are consistent with existing literature suggesting a role for structured health coaching in supporting patient self-management and reducing healthcare utilization [ 5 ].

One notable finding is that older patients demonstrated higher program engagement, with greater frequency of coaching calls and higher reported rates of symptom resolution. This pattern aligns with research indicating that older adults tend to engage more actively in health interventions, potentially due to increased health concerns and disease management needs [ 11 ]. Additionally, age showed a positive association with total claims paid, consistent with the well-established observation that older individuals typically incur higher healthcare costs [ 12 ]. These patterns suggest that while health coaching may benefit individuals across age groups, tailored strategies could potentially enhance engagement among younger policyholders, who may perceive a lower immediate need for such interventions. Age was found to be positively correlated with number of calls, number of symptoms reported as better, and number of symptoms reported as resolved. Older patients made more coaching calls and reported higher rates of symptom resolution, while also demonstrating higher overall healthcare costs. These associations may reflect heightened health awareness and greater chronic disease burdens commonly observed in older populations.

Gender differences in engagement patterns and reported outcomes also emerged as a notable theme. While female participants reported a higher number of symptoms, they made fewer calls than male counterparts. This pattern may reflect potential barriers to participation, such as competing household responsibilities or differential health-seeking behaviors. Notably, female participants showed a stronger negative association between the number of calls and total claims paid, suggesting that increased engagement may correspond to greater cost reductions for women. This finding underscores the potential value of gender-informed health coaching strategies that address identified barriers and support participation among women. In the Indian social context, these patterns may reflect broader structural factors, including differential household responsibilities and variable access to medical attention between genders.

The study also reveals an association between symptom resolution and claims reduction. The number of calls made by health coaches showed a positive correlation with both symptom resolution and symptom improvement. Furthermore, symptom resolution appeared to strengthen the association between coaching calls and total claims paid, suggesting that patients reporting symptom relief also demonstrated lower healthcare costs. This pattern is consistent with prior findings documenting associations between improved symptom management and reduced hospitalization rates and overall medical expenditures [ 13 ]. These results suggest that greater patient engagement in health coaching programs may correspond with economic benefits, building a case for further exploration of such initiatives by insurers.

An important observation concerns onboarding status, which was positively correlated with total claims paid, likely reflecting selection bias wherein individuals with more severe health conditions are preferentially enrolled in coaching programs and consequently file more claims. This finding is consistent with prior research indicating that high-risk patients are more likely to participate in health interventions due to perceived need for medical support [ 14 ]. However, the data also suggest that sustained engagement through multiple coaching sessions corresponds with cost reductions, indicating potential long-term financial and health associations with continued participation.

A particularly notable finding is the negative association between the number of coaching calls and total claims paid for preventable conditions. This association appeared stronger for patients who reported resolution of a greater number of symptoms. This pattern suggests that structured, personalized health coaching interventions may be associated with reduced financial burden related to preventable complications from chronic conditions such as diabetes, hypertension, and cardiovascular diseases. Given the substantial out-of-pocket healthcare expenditure in India, these findings are potentially relevant for both insurers and policymakers. They suggest that expanded access to such preventive programs warrants further investigation for potential public health and economic benefits [ 15 , 16 ].

The findings of this study suggest a potential shift in India's insurance-led health delivery paradigm: structured health coaching programs may be associated with measurable improvements in health status among high-risk, insured populations, bridging traditional distinctions between insurance coverage and health outcomes. The observed finding that 81% of engaged customers reported improvements in HbA1c, cholesterol, and blood pressure is consistent with patterns documented in global meta-analyses and extends this literature to India's market-driven, private insurance context - an area where evidence remains limited. The mechanisms underlying these observed associations likely involve behavioral pathways described in health coaching theory: personalized goal-setting, continuous monitoring, motivational support, and accountability may support behavioral change and treatment adherence, which, in turn, could be associated with improvements in glycemic and cardiometabolic control. Notably, the engagement definition employed in this study (successful onboarding plus continued interaction) captures an often-unmeasured dimension in effectiveness research: real-world engagement patterns that reflect actual intervention uptake. By operationalizing engagement and examining its association with reported clinical improvement, this study contributes evidence suggesting that coaching-based disease management approaches may be both clinically relevant and operationally feasible at scale in the Indian context. Future research should examine cost-effectiveness outcomes and long-term sustainability trajectories, particularly as India considers scaling such models across its expanding insurance base to address chronic disease burden disparities across income and geographic distribution.

Limitations and future research directions

Despite these promising results, this study has certain limitations. First, the reliance on self-reported symptoms may introduce bias, as patients' perceptions of improvement might not always align with objective clinical assessments. Future research should incorporate biometric and medical test data to validate self-reported outcomes. Second, while the study controlled for key demographic variables such as age and gender, additional factors such as socioeconomic status, educational background, and occupation could influence program engagement and health outcomes. Future studies should explore these aspects to provide a more comprehensive understanding of health coaching effectiveness. Third, the study primarily focused on short-term claims data, and a longitudinal analysis would be necessary to assess the sustained impact of health coaching on long-term healthcare costs and chronic disease progression.

Looking ahead, future research and policy implications should consider integrating health coaching with broader public health initiatives. Given the rapid expansion of India's digital health ecosystem, leveraging mobile health (mHealth) technologies and AI-driven personalized coaching could enhance program scalability and effectiveness. Additionally, insurers could explore incentive structures, such as reduced premiums for active participants, to further encourage policyholder engagement.

Conclusions

This study provides strong evidence supporting the effectiveness of insurer-led health coaching programs in India. Higher engagement in coaching sessions is associated with improved symptom resolution and reduced healthcare costs, particularly for females and older individuals. These findings highlight the need for targeted strategies to enhance engagement, reduce barriers to participation, and optimize program delivery. By shifting from a reactive to a preventive healthcare model, insurers and policymakers can play a crucial role in mitigating the growing burden of NCDs in India.

Appendices

Table 4
ICD level 1 and tags

ICD level 1Tags
A00-A09 - Intestinal infectious diseasesNon-preventable
A00-B99 - Certain infectious and parasitic diseasesNon-preventable
A01 - Typhoid and paratyphoid feversNon-preventable
A010 - Typhoid feverNon-preventable
A02 - Other salmonella infectionsNon-preventable
A0222 - Salmonella pneumoniaNon-preventable
A04 - Other bacterial intestinal infectionsNon-preventable
A06 - AmebiasisNon-preventable
A07 - Other protozoal intestinal diseasesNon-preventable
A08 - Viral and other specified intestinal infectionsNon-preventable
A09 - Infectious gastroenteritis and colitis, unspecifiedNon-preventable
A15 - Respiratory tuberculosisNon-preventable
A15-A19 - TuberculosisNon-preventable
A18 - Tuberculosis of other organsNon-preventable
A1801 - Tuberculosis of spineNon-preventable
A20-A28 - Certain zoonotic bacterial diseasesNon-preventable
A30-A49 - Other bacterial diseasesNon-preventable
A36 - DiphtheriaNon-preventable
A37 - Whooping coughNon-preventable
A38 - Scarlet feverNon-preventable
A40 - Streptococcal sepsisNon-preventable
A41 - Other sepsisNon-preventable
A49 - Bacterial infection of unspecified siteNon-preventable
A54 - Gonococcal infectionNon-preventable
A66 - YawsNon-preventable
A75-A79 - RickettsiosesNon-preventable
A80-A89 - Viral and prion infections of the central nervous systemNon-preventable
A83 - Mosquito-borne viral encephalitisNon-preventable
A90 - Dengue fever [classical dengue]Non-preventable
A90-A99 - Arthropod-borne viral fevers and viral hemorrhagic feversNon-preventable
A92 - Other mosquito-borne viral feversNon-preventable
A98 - Other viral hemorrhagic fevers, not elsewhere classifiedNon-preventable
Abdominal and pelvic pain (R10)Non-preventable
Abnormal blood-pressure reading, without diagnosis (R03)Preventable
Abnormal tumor markers (R97)Non-preventable
Abnormalities of heart beat (R00)Preventable
Abscess of anal and rectal regions (K61)Non-preventable
Absent, scanty and rare menstruation (N91)Non-preventable
Acc hit, strk, kick, twist, bite or scratch by another prsn (W50)Non-preventable
Acquired hemolytic anemia (D59)Preventable
Acute appendicitis (K35)Non-preventable
Acute bronchiolitis (J21)Non-preventable
Acute bronchitis (J20)Preventable
Acute hepatitis A (B15)Non-preventable
Acute kidney failure (N17)Non-preventable
Acute pancreatitis (K85)Preventable
Acute pharyngitis (J02)Non-preventable
Acute pyelonephritis (N10)Preventable
Acute sinusitis (J01)Preventable
Acute tonsillitis (J03)Preventable
Acute upper resp infections of multiple and unsp sites (J06)Non-preventable
Adverse effects, not elsewhere classified (T78)Non-preventable
Age-related cataract (H25)Non-preventable
Allergy status to drug/meds/biol subst (Z88)Non-preventable
Amebiasis (A06)Non-preventable
Angina pectoris (I20)Preventable
Aphagia and dysphagia (R13)Non-preventable
Arenaviral hemorrhagic fever (A96)Non-preventable
Asthma (J45)Preventable
Atrial fibrillation and flutter (I48)Preventable
B00-B09 - Viral infections characterized by skin and mucous membrane lesionsNon-preventable
B02 - Zoster [herpes zoster]Non-preventable
B15-B19 - Viral hepatitisNon-preventable
B17 - Other acute viral hepatitisNon-preventable
B25 - Cytomegaloviral diseaseNon-preventable
B25-B34 - Other viral diseasesNon-preventable
B26 - MumpsNon-preventable
B34 - Viral infection of unspecified siteNon-preventable
B35-B49 - MycosesNon-preventable
B37 - CandidiasisNon-preventable
B42 - SporotrichosisNon-preventable
B43 - Chromomycosis and phaeomycotic abscessNon-preventable
B50-B64 - Protozoal diseasesNon-preventable
B51 - Plasmodium vivax malariaNon-preventable
B66 - Other fluke infectionsNon-preventable
B965 - Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhereNon-preventable
Bacterial meningitis, not elsewhere classified (G00)Non-preventable
Bacterial pneumonia, not elsewhere classified (J15)Non-preventable
Bacterial sepsis of newborn (P36)Non-preventable
Benign lipomatous neoplasm (D17)Non-preventable
Benign neoplasm of brain and oth prt central nervous system (D33)Non-preventable
Benign neoplasm of male genital organs (D29)Non-preventable
Benign neuroendocrine tumors (D3A)Non-preventable
Bronchitis, not specified as acute or chronic (J40)Non-preventable
Burn and corrosion of head, face, and neck (T20)Non-preventable
Burn and corrosion of shoulder/upper limb, except wrist and hand (T22)Non-preventable
Burns classified accord extent body involvement (T31)Non-preventable
C00 - Malignant neoplasm of lipNon-preventable
C00-C14 - Malignant neoplasms of lip, oral cavity and pharynxNon-preventable
C00-D49 - NeoplasmsNon-preventable
C02 - Malignant neoplasm of other and unspecified parts of tongueNon-preventable
C029 - Malignant neoplasm of tongue, unspecifiedNon-preventable
C06 - Malignant neoplasm of other and unspecified parts of mouthNon-preventable
C08 - Malignant neoplasm of other and unspecified major salivary glandsNon-preventable
C13 - Malignant neoplasm of hypopharynxNon-preventable
C15 - Malignant neoplasm of esophagusNon-preventable
C15-C26 - Malignant neoplasms of digestive organsNon-preventable
C16 - Malignant neoplasm of stomachNon-preventable
C169 - Malignant neoplasm of stomach, unspecifiedNon-preventable
C17 - Malignant neoplasm of small intestineNon-preventable
C18 - Malignant neoplasm of colonNon-preventable
C18. 1 – CarcinomaNon-preventable
C181 - Malignant neoplasm of appendixNon-preventable
C24 - Malignant neoplasm of other and unspecified parts of biliary tractNon-preventable
C25 - Malignant neoplasm of pancreasNon-preventable
C30-C39 - Malignant neoplasms of respiratory and intrathoracic organsNon-preventable
C34 - Malignant neoplasm of bronchus and lungNon-preventable
C41 - Malignant neoplasm of bone and articular cartilage of other and unspecified sitesNon-preventable
C43 - Malignant melanoma of skinNon-preventable
C44 - Other and unspecified malignant neoplasm of skinNon-preventable
C45-C49 - Malignant neoplasms of mesothelial and soft tissueNon-preventable
C46 - Kaposi's sarcomaNon-preventable
C49 - Malignant neoplasm of other connective and soft tissueNon-preventable
C50 - Malignant neoplasm of breastNon-preventable
C50011 - Malignant neoplasm of nipple and areola, right female breastNon-preventable
C51-C58 - Malignant neoplasms of female genital organsNon-preventable
C53 - Malignant neoplasm of cervix uteriNon-preventable
C54 - Malignant neoplasm of corpus uteriNon-preventable
C56 - Malignant neoplasm of ovaryNon-preventable
C569 - Malignant neoplasm of unspecified ovaryNon-preventable
C60 - Malignant neoplasm of penisNon-preventable
C60-C63 - Malignant neoplasms of male genital organsNon-preventable
C64 - Malignant neoplasm of kidney, except renal pelvisNon-preventable
C64-C68 - Malignant neoplasms of urinary tractNon-preventable
C67 - Malignant neoplasm of bladderNon-preventable
C69-C72 - Malignant neoplasms of eye, brain and other parts of central nervous systemNon-preventable
C71 - Malignant neoplasm of brainNon-preventable
C719 - Malignant neoplasm of brain, unspecifiedNon-preventable
C73-C75 - Malignant neoplasms of thyroid and other endocrine glandsNon-preventable
C76 - Malignant neoplasm of other and ill-defined sitesNon-preventable
C76-C80 - Malignant neoplasms of ill-defined, other secondary and unspecified sitesNon-preventable
C78 - Secondary malignant neoplasm of respiratory and digestive organsNon-preventable
C7A - Malignant neuroendocrine tumorsNon-preventable
C7A - Malignant neuroendocrine tumorsNon-preventable
C80 - Malignant neoplasm without specification of siteNon-preventable
C81 - Hodgkin lymphomaNon-preventable
C81-C96 - Malignant neoplasms of lymphoid, hematopoietic and related tissueNon-preventable
C84 - Mature T/NK-cell lymphomasNon-preventable
C90 - Multiple myeloma and malignant plasma cell neoplasmsNon-preventable
C91 - Lymphoid leukemiaNon-preventable
C92 - Myeloid leukemiaNon-preventable
Calculus of kidney and ureter (N20)Non-preventable
Calculus of lower urinary tract (N21)Non-preventable
Candidiasis (B37)Non-preventable
carcinoma breast - carcinoma breastNon-preventable
Carcinoma in situ of breast (D05)Non-preventable
Carcinoma in situ of oral cavity, esophagus and stomach (D00)Non-preventable
Carcinoma in situ of other and unspecified digestive organs (D01)Non-preventable
Carcinoma in situ of other and unspecified genital organs (D07)Non-preventable
Cardiomyopathy (I42)Preventable
Cellulitis and acute lymphangitis (L03)Non-preventable
Cerebral infarction (I63)Preventable
Certain current complications following ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction ≤ 28 day (I23)Preventable
Cholecystitis (K81)Non-preventable
Cholelithiasis (K80)Non-preventable
Cholera (A00)Non-preventable
Chronic ischemic heart disease (I25)Preventable
Chronic kidney disease (CKD) (N18)Non-preventable
Chronic sinusitis (J32)Preventable
Chronic viral hepatitis (B18)Non-preventable
Complications and ill-defined descriptions of heart disease (I51)Preventable
Complications of internal orthopedic prosthetic devices, implants and grafts (T84)Non-preventable
Conductive and sensorineural hearing loss (H90)Non-preventable
Contact with dog (W54)Non-preventable
Convulsions, not elsewhere classified (R56)Non-preventable
Cutaneous abscess, furuncle and carbuncle (L02)Non-preventable
Cystitis (N30)Non-preventable
D00 - Carcinoma in situ of oral cavity, esophagus and stomachNon-preventable
D00-D09 - In situ neoplasmsNon-preventable
D01 - Carcinoma in situ of other and unspecified digestive organsNon-preventable
D05 - Carcinoma in situ of breastNon-preventable
D10 - Benign neoplasm of mouth and pharynxNon-preventable
D10-D36 - Benign neoplasms, except benign neuroendocrine tumorsNon-preventable
D11 - Benign neoplasm of major salivary glandsNon-preventable
D17 - Benign lipomatous neoplasmNon-preventable
D22 - Melanocytic neviNon-preventable
D23 - Other benign neoplasms of skinNon-preventable
D24 - Benign neoplasm of breastNon-preventable
D25 - Leiomyoma of uterusNon-preventable
D259 - Leiomyoma of uterus, unspecifiedNon-preventable
D27 - Benign neoplasm of ovaryNon-preventable
D29 - Benign neoplasm of male genital organsNon-preventable
D31 - Benign neoplasm of eye and adnexaNon-preventable
D32 - Benign neoplasm of meningesNon-preventable
D35 - Benign neoplasm of other and unspecified endocrine glandsNon-preventable
D36 - Benign neoplasm of other and unspecified sitesNon-preventable
D37-D48 - Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromesNon-preventable
D43 - Neoplasm of uncertain behavior of brain and central nervous systemNon-preventable
D46 - Myelodysplastic syndromesNon-preventable
D469 - Myelodysplastic syndrome, unspecifiedNon-preventable
D47 - Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissueNon-preventable
D48 - Neoplasm of uncertain behavior of other and unspecified sitesNon-preventable
D50 - Iron deficiency anemiaPreventable
D50-D53 - Nutritional anemiasPreventable
D51 - Vitamin B12 deficiency anemiaPreventable
D60-D64 - Aplastic and other anemias and other bone marrow failure syndromesNon-preventable
D61 - Other aplastic anemias and other bone marrow failure syndromesNon-preventable
D63 - Anemia in chronic diseases classified elsewhereNon-preventable
D64 - Other anemiasPreventable
D65-D69 - Coagulation defects, purpura and other hemorrhagic conditionsNon-preventable
D69 - Purpura and other hemorrhagic conditionsNon-preventable
Dengue fever [classical dengue] (A90)Non-preventable
Dengue hemorrhagic fever (A91)Non-preventable
Dermatopolymyositis (M33)Non-preventable
Diabetes mellitus due to underlying condition (E08)Preventable
Diseases of vocal cords and larynx, not elsewhere classified (J38)Non-preventable
Dislocation and sprain of joints and ligaments at ankle, foot and toe level (S93)Non-preventable
Disloc and sprain of joints and ligaments of shoulder girdle (S43)Non-preventable
Dislocation and sprain of joints and ligaments of elbow (S53)Non-preventable
Dislocation and sprain of joints and ligaments of knee (S83)Non-preventable
Disorder of continuity of bone (M84)Non-preventable
Disorders of globe (H44)Non-preventable
Disorders of lipoprotein metabolism and other lipidemias (E78)Preventable
Disorders of prepuce (N47)Non-preventable
Disorders of trigeminal nerve (G50)Non-preventable
Disorders of vestibular function (H81)Non-preventable
Disorders of vitreous body (H43)Non-preventable
Dizziness and giddiness (R42)Preventable
Dorsalgia (M54)Preventable
Drug or chemical induced diabetes mellitus (E09)Preventable
E00-E07 - Disorders of thyroid glandPreventable
E00-E89 - Endocrine, nutritional and metabolic diseasesPreventable
E03 - Other hypothyroidismPreventable
E08 - Diabetes mellitus due to underlying conditionPreventable
E08-E13 - Diabetes mellitusPreventable
E09 – Drug- or chemical -induced diabetes mellitusNon-preventable
E11 - Type 2 diabetes mellitusPreventable
E13 - Other specified diabetes mellitusPreventable
E15-E16 - Other disorders of glucose regulation and pancreatic internal secretionNon-preventable
E16 - Other disorders of pancreatic internal secretionPreventable
E23 - Hypofunction and other disorders of the pituitary glandNon-preventable
E28 - Ovarian dysfunctionNon-preventable
E84 - Cystic fibrosisNon-preventable
E86 - Volume depletionNon-preventable
E87 - Other disorders of fluid, electrolyte and acid-base balanceNon-preventable
E89 - Postprocedural endocrine and metabolic complications and disorders, not elsewhere classifiedNon-preventable
Ectopic pregnancy (O00)Non-preventable
Effects of heat and light (T67)Preventable
Elevated blood glucose level (R73)Preventable
Emergency use of U07 (U07)Non-preventable
Encounter for general exam w/o complaint, susp or reported diagnosis (Z00)Non-preventable
Encounter for adjustment and management of implanted device (Z45)Non-preventable
Encounter for care involving renal dialysis (Z49)Non-preventable
Encounter for fitting and adjustment of other devices (Z46)Non-preventable
Endometriosis (N80)Non-preventable
Enthesopathies, lower limb, excluding foot (M76)Non-preventable
Epilepsy and recurrent seizures (G40)Non-preventable
Essential (primary) hypertension (I10)Preventable
Excessive, frequent and irregular menstruation (N92)Preventable
F06 - Other mental disorders due to known physiological conditionNon-preventable
Facial nerve disorders (G51)Non-preventable
Femoral hernia (K41)Non-preventable
Fever of other and unknown origin (R50)Non-preventable
Fissure and fistula of anal and rectal regions (K60)Preventable
Follicular cysts of skin and subcutaneous tissue (L72)Non-preventable
Fracture at wrist and hand level (S62)Non-preventable
Fracture of cervical vertebra and other parts of neck (S12)Non-preventable
Fracture of femur (S72)Non-preventable
Fracture of foot and toe, except ankle (S92)Non-preventable
Fracture of forearm (S52)Non-preventable
Fracture of lower leg, including ankle (S82)Non-preventable
Fracture of lumbar spine and pelvis (S32)Non-preventable
Fracture of rib(s), sternum and thoracic spine (S22)Non-preventable
Fracture of shoulder and upper arm (S42)Non-preventable
Fracture of skull and facial bones (S02)Non-preventable
G03 - Meningitis due to other and unspecified causesNon-preventable
G04 - Encephalitis, myelitis and encephalomyelitisNon-preventable
G31 - Other degenerative diseases of nervous system, not elsewhere classifiedNon-preventable
G40 - Epilepsy and recurrent seizuresNon-preventable
G40-G47 - Episodic and paroxysmal disordersNon-preventable
G43 - MigraineNon-preventable
G45 - Transient cerebral ischemic attacks and related syndromesPreventable
G459 - Transient cerebral ischemic attack, unspecifiedNon-preventable
G46 - Vascular syndromes of brain in cerebrovascular diseasesPreventable
G50-G59 - Nerve, nerve root and plexus disordersNon-preventable
G52 - Disorders of other cranial nervesNon-preventable
G56 - Mononeuropathies of upper limbNon-preventable
G560 - Carpal tunnel syndromeNon-preventable
G5603 - Carpal tunnel syndrome, bilateral upper limbsNon-preventable
G57 - Mononeuropathies of lower limbPreventable
G60-G65 - Polyneuropathies and other disorders of the peripheral nervous systemNon-preventable
G61 - Inflammatory polyneuropathyNon-preventable
G80-G83 - Cerebral palsy and other paralytic syndromesNon-preventable
G81 - Hemiplegia and hemiparesisNon-preventable
G89-G99 - Other disorders of the nervous systemPreventable
G93 - Other disorders of brainNon-preventable
G97 - Intraoperative and postprocedural complications and disorders of nervous system, not elsewhere classifiedNon-preventable
Gangrene, not elsewhere classified (I96)Preventable
Gastritis and duodenitis (K29)Preventable
Glaucoma (H40)Non-preventable
Granulomatous disorders of skin and subcutaneous tissue (L92)Non-preventable
H00 - Hordeolum and chalazionNon-preventable
H00-H05 - Disorders of eyelid, lacrimal system and orbitNon-preventable
H00-H59 - Diseases of the eye and adnexaNon-preventable
H01 - Other inflammation of eyelidNon-preventable
H02 - Other disorders of eyelidNon-preventable
H04 - Disorders of lacrimal systemNon-preventable
H040 - DacryoadenitisNon-preventable
H05 - Disorders of orbitNon-preventable
H10 - ConjunctivitisNon-preventable
H11 - Other disorders of conjunctivaNon-preventable
H18 - Other disorders of corneaNon-preventable
H25 - Age-related cataractNon-preventable
H25-H28 - Disorders of lensNon-preventable
H2501 - Cortical age-related cataractNon-preventable
H25011 - Cortical age-related cataract, right eyeNon-preventable
H25012 - Cortical age-related cataract, left eyeNon-preventable
H25013 - Cortical age-related cataract, bilateralNon-preventable
H2511 - Age-related nuclear cataract, right eyeNon-preventable
H2511 - Cortical age-related cataract, right eyeNon-preventable
H2512 - Age-related nuclear cataract, left eyeNon-preventable
H252 - Age-related cataract, morgagnian typeNon-preventable
H25812 - Combined forms of age-related cataract, left eyeNon-preventable
H259 - Unspecified age-related cataractNon-preventable
H26 - Other cataractNon-preventable
H269 - Unspecified cataractNon-preventable
H30 - Chorioretinal inflammationNon-preventable
H30-H36 - Disorders of choroid and retinaNon-preventable
H31 - Other disorders of choroidNon-preventable
H33 - Retinal detachments and breaksNon-preventable
H330 - Retinal detachment with retinal breakNon-preventable
H34 - Retinal vascular occlusionsNon-preventable
H348120 - Central retinal vein occlusion, left eye, with macular edemaNon-preventable
H35 - Other retinal disordersNon-preventable
H40 - GlaucomaNon-preventable
H40-H42 - GlaucomaNon-preventable
H43 - Disorders of vitreous bodyNon-preventable
H43-H44 - Disorders of vitreous body and globeNon-preventable
H44 - Disorders of globeNon-preventable
H46 - Optic neuritisNon-preventable
H50 - Other strabismusNon-preventable
H53 - Visual disturbancesNon-preventable
H53-H54 - Visual disturbances and blindnessNon-preventable
H54 - Blindness and low visionNon-preventable
H55-H57 - Other disorders of eye and adnexaNon-preventable
H57 - Other disorders of eye and adnexaNon-preventable
H59 - Intraoperative and postprocedural complications and disorders of eye and adnexa, not elsewhere classifiedNon-preventable
H60 - Otitis externaNon-preventable
H6090 - Unspecified otitis externa, unspecified earNon-preventable
H65 - Nonsuppurative otitis mediaNon-preventable
H65-H75 - Diseases of middle ear and mastoidNon-preventable
H66 - Suppurative and unspecified otitis mediaNon-preventable
H72 - Perforation of tympanic membraneNon-preventable
H74 - Other disorders of middle ear mastoidNon-preventable
H80 - OtosclerosisNon-preventable
H81 - Disorders of vestibular functionNon-preventable
H83 - Other diseases of inner earNon-preventable
H90 - Conductive and sensorineural hearing lossNon-preventable
H90-H94 - Other disorders of earNon-preventable
H91 - Other and unspecified hearing lossNon-preventable
H92 - Otalgia and effusion of earNon-preventable
Headache (R51)Preventable
Heart failure (I50)Preventable
Hemangioma and lymphangioma, any site (D18)Non-preventable
Hematuria (R31)Non-preventable
Hemorrhage from respiratory passages (R04)Non-preventable
Hemorrhoids and perianal venous thrombosis (K64)Preventable
Hepatic failure, not elsewhere classified (K72)Non-preventable
Herpesviral [herpes simplex] infections (B00)Non-preventable
Hydrocele and spermatocele - Hydrocele and spermatoceleNon-preventable
Hydrocele and spermatocele (N43)Non-preventable
Hypertensive crisis (I16)Preventable
Hypertensive heart and chronic kidney disease (I13)Preventable
Hypertensive heart disease (I11)Preventable
I10 - Essential (primary) hypertensionPreventable
I10-I16 - Hypertensive diseasesPreventable
I11 - Hypertensive heart diseasePreventable
I15 - Secondary hypertensionPreventable
I16 - Hypertensive crisisPreventable
I20 - Angina pectorisNon-preventable
I20-I25 - Ischemic heart diseasesPreventable
I200 - Unstable anginaNon-preventable
I21 - ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarctionPreventable
I214 - Non-ST elevation (NSTEMI) myocardial infarctionPreventable
I23 - Certain current complications following ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction (within the 28 -day period)Non-preventable
I24 - Other acute ischemic heart diseasesPreventable
I249 - Acute ischemic heart disease, unspecifiedPreventable
I25 - Chronic ischemic heart diseasePreventable
I251 - Atherosclerotic heart disease of native coronary arteryPreventable
I2510 - Atherosclerotic heart disease of native coronary artery without angina pectorisPreventable
I25810 - Atherosclerosis of coronary artery bypass graft(s) without angina pectorisPreventable
I26 - Pulmonary embolismNon-preventable
I26-I28 - Pulmonary heart disease and diseases of pulmonary circulationPreventable
I30-I52 - Other forms of heart diseasePreventable
I31 - Other diseases of pericardiumNon-preventable
I35 - Nonrheumatic aortic valve disordersPreventable
I42 - CardiomyopathyPreventable
I44 - Atrioventricular and left bundle-branch blockPreventable
I45 - Other conduction disordersPreventable
I47 - Paroxysmal tachycardiaPreventable
I48 - Atrial fibrillation and flutterPreventable
I49 - Other cardiac arrhythmiasNon-preventable
I50 - Heart failurePreventable
I60-I69 - Cerebrovascular diseasesPreventable
I61 - Nontraumatic intracerebral hemorrhagePreventable
I62 - Other and unspecified nontraumatic intracranial hemorrhageNon-preventable
I63 - Cerebral infarctionPreventable
I639 - Cerebral infarction, unspecifiedPreventable
I67 - Other cerebrovascular diseasesNon-preventable
I69 - Sequelae of cerebrovascular diseaseNon-preventable
I69351 - Hemiplegia and hemiparesis following cerebral infarction affecting right dominant sideNon-preventable
I70 - AtherosclerosisPreventable
I70-I79 - Diseases of arteries, arterioles and capillariesPreventable
I72 - Other aneurysmNon-preventable
I77 - Other disorders of arteries and arteriolesNon-preventable
I80-I89 - Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classifiedNon-preventable
I82 - Other venous embolism and thrombosisPreventable
I83 - Varicose veins of lower extremitiesPreventable
I83813 - Varicose veins of bilateral lower extremities with painPreventable
I87 - Other disorders of veinsNon-preventable
Illness, unspecified (R69)Non-preventable
Infectious gastroenteritis and colitis, unspecified (A09)Non-preventable
Infectious mononucleosis (B27)Non-preventable
Inflammatory diseases of prostate (N41)Non-preventable
Inflammatory disorders of breast (N61)Non-preventable
Inflammatory disorders of male genital organs, not elsewhere classified (N49)Non-preventable
Inflammatory polyneuropathy (G61)Non-preventable
Influenza due to certain identified influenza viruses (J09)Non-preventable
Influenza due to other identified influenza virus (J10)Non-preventable
Influenza due to unidentified influenza virus (J11)Non-preventable
Inguinal hernia (K40)Non-preventable
Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level (S34)Non-preventable
Injury of blood vessels at wrist and hand level (S65)Non-preventable
Injury of eye and orbit (S05)Non-preventable
Injury of intra-abdominal organs (S36)Non-preventable
Injury of nerves at shoulder and upper arm level (S44)Non-preventable
Injury of other and unspecified intrathoracic organs (S27)Non-preventable
Internal derangement of knee (M23)Non-preventable
Intracranial and intraspinal abscess and granuloma (G06)Non-preventable
Intracranial injury (S06)Non-preventable
Intraoperative and postprocedural complications and disorders of digestive system, not elsewhere classified (K91)Non-preventable
Intraoperative and postprocedural complications and disorders of genitourinary system, not elsewhere classified (N99)Non-preventable
Intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified (M96)Non-preventable
Intraoperative and postprocedural complications and disorders of nervous system, not elsewhere classified (G97)Non-preventable
Iron deficiency anemia (D50)Preventable
IVDP - IVDPNon-preventable
J00-J06 - Acute upper respiratory infectionsNon-preventable
J00-J99 - Diseases of the respiratory systemNon-preventable
J01 - Acute sinusitisPreventable
J03 - Acute tonsillitisNon-preventable
J0390 - Acute tonsillitis, unspecifiedNon-preventable
J06 - Acute upper respiratory infections of multiple and unspecified sitesNon-preventable
J09-J18 - Influenza and pneumoniaNon-preventable
J10 - Influenza due to other identified influenza virusNon-preventable
J11 - Influenza due to unidentified influenza virusNon-preventable
J12 - Viral pneumonia, not elsewhere classifiedNon-preventable
J18 - Pneumonia, unspecified organismNon-preventable
J20 - Acute bronchitisNon-preventable
J20-J22 - Other acute lower respiratory infectionsNon-preventable
J30-J39 - Other diseases of upper respiratory tractNon-preventable
J32 - Chronic sinusitisPreventable
J33 - Nasal polypNon-preventable
J34 - Other and unspecified disorders of nose and nasal sinusesNon-preventable
J342 - Deviated nasal septumNon-preventable
J35 - Chronic diseases of tonsils and adenoidsNon-preventable
J38 - Diseases of vocal cords and larynx, not elsewhere classifiedNon-preventable
J40-J47 - Chronic lower respiratory diseasesNon-preventable
J44 - Other chronic obstructive pulmonary diseaseNon-preventable
J45 - AsthmaPreventable
J479 - Bronchiectasis, uncomplicatedNon-preventable
J69 - Pneumonitis due to solids and liquidsNon-preventable
J80-J84 - Other respiratory diseases principally affecting the interstitiumNon-preventable
J84 - Other interstitial pulmonary diseasesNon-preventable
J86 - PyothoraxNon-preventable
J90-J94 - Other diseases of the pleuraNon-preventable
J91 - Pleural effusion in conditions classified elsewhereNon-preventable
J93 - Pneumothorax and air leakNon-preventable
J94 - Other pleural conditionsNon-preventable
J95 - Intraoperative and postprocedural complications and disorders of respiratory system, not elsewhere classifiedNon-preventable
J95830 - Postprocedural hemorrhage of a respiratory system organ or structure following a respiratory system procedureNon-preventable
J96 - Respiratory failure, not elsewhere classifiedNon-preventable
J96-J99 - Other diseases of the respiratory systemNon-preventable
J98 - Other respiratory disordersNon-preventable
K00-K14 - Diseases of oral cavity and salivary glandsNon-preventable
K00-K95 - Diseases of the digestive systemNon-preventable
K11 - Diseases of salivary glandsNon-preventable
K12 - Stomatitis and related lesionsNon-preventable
K13 - Other diseases of lip and oral mucosaNon-preventable
K20-K31 - Diseases of esophagus, stomach and duodenumNon-preventable
K28 - Gastrojejunal ulcerNon-preventable
K29 - Gastritis and duodenitisNon-preventable
K31 - Other diseases of stomach and duodenumNon-preventable
K35 - Acute appendicitisNon-preventable
K35-K38 - Diseases of appendixNon-preventable
K40 - Inguinal herniaNon-preventable
K40-K46 - HerniaNon-preventable
K42 - Umbilical herniaNon-preventable
K43 - Ventral herniaNon-preventable
K46 - Unspecified abdominal herniaNon-preventable
K469 - Unspecified abdominal hernia without obstruction or gangreneNon-preventable
K50-K52 - Noninfective enteritis and colitisNon-preventable
K51 - Ulcerative colitisPreventable
K52 - Other and unspecified noninfective gastroenteritis and colitisNon-preventable
K529 - Noninfective gastroenteritis and colitis, unspecifiedNon-preventable
K55-K64 - Other diseases of intestinesNon-preventable
K57 - Diverticular disease of intestinePreventable
K60 - Fissure and fistula of anal and rectal regionsNon-preventable
K602 - Anal fissure, unspecifiedPreventable
K603 - Anal fistulaNon-preventable
K61 - Abscess of anal and rectal regionsNon-preventable
K62 - Other diseases of anus and rectumPreventable
K63 - Other diseases of intestineNon-preventable
K64 - Hemorrhoids and perianal venous thrombosisPreventable
K649 - Unspecified hemorrhoidsPreventable
K70-K77 - Diseases of liverNon-preventable
K74 - Fibrosis and cirrhosis of liverPreventable
K75 - Other inflammatory liver diseasesNon-preventable
K76 - Other diseases of liverPreventable
K80 - CholelithiasisNon-preventable
K80-K87 - Disorders of gallbladder, biliary tract and pancreasNon-preventable
K8000 - Calculus of gallbladder with acute cholecystitis without obstructionNon-preventable
K81 - CholecystitisNon-preventable
K83 - Other diseases of biliary tractNon-preventable
K85 - Acute pancreatitisNon-preventable
K86 - Other diseases of pancreasNon-preventable
K90-K95 - Other diseases of the digestive systemNon-preventable
K91 - Intraoperative and postprocedural complications and disorders of digestive system, not elsewhere classifiedNon-preventable
K92 - Other diseases of digestive systemNon-preventable
Keratitis (H16)Non-preventable
L00-L08 - Infections of the skin and subcutaneous tissueNon-preventable
L02 - Cutaneous abscess, furuncle and carbuncleNon-preventable
L03 - Cellulitis and acute lymphangitisNon-preventable
L05 - Pilonidal cyst and sinusNon-preventable
L08 - Other local infections of skin and subcutaneous tissueNon-preventable
L40 - PsoriasisNon-preventable
L49-L54 - Urticaria and erythemaNon-preventable
L60-L75 - Disorders of skin appendagesNon-preventable
L72 - Follicular cysts of skin and subcutaneous tissueNon-preventable
L720 - Epidermal cystNon-preventable
L73 - Other follicular disordersNon-preventable
L80-L99 - Other disorders of the skin and subcutaneous tissueNon-preventable
L89 - Pressure ulcerPreventable
L97 - Non-pressure chronic ulcer of lower limb, not elsewhere classifiedNon-preventable
Leiomyoma of uterus (D25)Non-preventable
Localized swelling, mass and lump of skin and subcutaneous tissue (R22)Non-preventable
M00 - Pyogenic arthritisNon-preventable
M00-M99 - Diseases of the musculoskeletal system and connective tissueNon-preventable
M02 - Postinfective and reactive arthropathiesNon-preventable
M05 - Rheumatoid arthritis with rheumatoid factorNon-preventable
M05-M14 - Inflammatory polyarthropathiesNon-preventable
M12 - Other and unspecified arthropathyNon-preventable
M15 - PolyosteoarthritisNon-preventable
M15-M19 - OsteoarthritisNon-preventable
M16 - Osteoarthritis of hipNon-preventable
M17 - Osteoarthritis of kneeNon-preventable
M170 - Bilateral primary osteoarthritis of kneeNon-preventable
M189 - Osteoarthritis of first carpometacarpal joint, unspecifiedNon-preventable
M19 - Other and unspecified osteoarthritisPreventable
M20 - Acquired deformities of fingers and toesNon-preventable
M20-M25 - Other joint disordersNon-preventable
M21 - Other acquired deformities of limbsNon-preventable
M22 - Disorder of patellaNon-preventable
M23 - Internal derangement of kneeNon-preventable
M24 - Other specific joint derangementsNon-preventable
M25 - Other joint disorder, not elsewhere classifiedPreventable
M30-M36 - Systemic connective tissue disordersNon-preventable
M31 - Other necrotizing vasculopathiesNon-preventable
M32 - Systemic lupus erythematosus (SLE)Non-preventable
M43 - Other deforming dorsopathiesNon-preventable
M45-M49 - SpondylopathiesPreventable
M46 - Other inflammatory spondylopathiesNon-preventable
M47 - SpondylosisPreventable
M48 - Other spondylopathiesNon-preventable
M50 - Cervical disc disordersNon-preventable
M50-M54 - Other dorsopathiesNon-preventable
M51 - Thoracic, thoracolumbar, and lumbosacral intervertebral disc disordersNon-preventable
M53 - Other and unspecified dorsopathies, not elsewhere classifiedNon-preventable
M54 - DorsalgiaPreventable
M62 - Other disorders of muscleNon-preventable
M6208 - Separation of muscle (nontraumatic), other siteNon-preventable
M65 - Synovitis and tenosynovitisNon-preventable
M65-M67 - Disorders of synovium and tendonNon-preventable
M65311 - Trigger thumb, right thumbNon-preventable
M654 - Radial styloid tenosynovitis [de Quervain]Non-preventable
M66 - Spontaneous rupture of synovium and tendonNon-preventable
M67 - Other disorders of synovium and tendonNon-preventable
M70-M79 - Other soft tissue disordersNon-preventable
M75 - Shoulder lesionsNon-preventable
M75122 - Complete rotator cuff tear or rupture of left shoulder, not specified as traumaticNon-preventable
M79 - Other and unspecified soft tissue disorders, not elsewhere classifiedNon-preventable
M80 - Osteoporosis with current pathological fractureNon-preventable
M80-M85 - Disorders of bone density and structureNon-preventable
M84 - Disorder of continuity of boneNon-preventable
M85 - Other disorders of bone density and structureNon-preventable
M87 - OsteonecrosisNon-preventable
M8708 - Idiopathic aseptic necrosis of bone, other siteNon-preventable
M94 - Other disorders of cartilageNon-preventable
M96 - Intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classifiedNon-preventable
Malignant immunoproliferative diseases and certain other B-cell lymphomas (C88)Non-preventable
Malignant melanoma of skin (C43)Non-preventable
Malignant neoplasm of bone and articular cartilage of other and unspecified sites (C41)Non-preventable
Malignant neoplasm of breast (C50)Non-preventable
Malignant neoplasm of bronchus and lung (C34)Non-preventable
Malignant neoplasm of cervix uteri (C53)Non-preventable
Malignant neoplasm of corpus uteri (C54)Non-preventable
Malignant neoplasm of endo glands and related structures (C75)Non-preventable
Malignant neoplasm of esophagus (C15)Non-preventable
Malignant neoplasm of hypopharynx (C13)Non-preventable
Malignant neoplasm of kidney, except renal pelvis (C64)Non-preventable
Malignant neoplasm of larynx (C32)Non-preventable
Malignant neoplasm of oropharynx (C10)Non-preventable
Malignant neoplasm of other and ill-defined sites (C76)Non-preventable
Malignant neoplasm of other and unspecified female genital organs (C57)Non-preventable
Malignant neoplasm of other and unspecified parts of biliary tract (C24)Non-preventable
Malignant neoplasm of other and unspecified parts of mouth (C06)Non-preventable
Malignant neoplasm of other and unspecified parts of tongue (C02)Non-preventable
Malignant neoplasm of ovary (C56)Non-preventable
Malignant neoplasm of parotid gland (C07)Non-preventable
Malignant neoplasm of prostate (C61)Non-preventable
Malignant neoplasm of rectum (C20)Non-preventable
Malignant neoplasm of stomach (C16)Non-preventable
Malignant neoplasm without specification of site (C80)Non-preventable
Menopausal and other perimenopausal disorders (N95)Preventable
Merkel cell carcinoma (C4A)Non-preventable
Mononeuropathies of upper limb (G56)Non-preventable
Motor- or nonmotor-vehicle accident, type of vehicle unspecified (V89)Non-preventable
Mumps (B26)Non-preventable
Myositis (M60)Non-preventable
N00-N08 - Glomerular diseasesNon-preventable
N04 - Nephrotic syndromeNon-preventable
N10 - Acute pyelonephritisPreventable
N10-N16 - Renal tubulo-interstitial diseasesPreventable
N11 - Chronic tubulo-interstitial nephritisNon-preventable
N13 - Obstructive and reflux uropathyNon-preventable
N17 - Acute kidney failureNon-preventable
N17-N19 - Acute kidney failure and chronic kidney diseaseNon-preventable
N18 - Chronic kidney disease (CKD)Non-preventable
N189 - Chronic kidney disease, unspecifiedNon-preventable
N20 - Calculus of kidney and ureterNon-preventable
N20-N23 - UrolithiasisNon-preventable
N200 - Calculus of kidneyNon-preventable
N201 - Calculus of ureterNon-preventable
N209 - Urinary calculus, unspecifiedNon-preventable
N21 - Calculus of lower urinary tractNon-preventable
N25-N29 - Other disorders of kidney and ureterNon-preventable
N28 - Other disorders of kidney and ureter, not elsewhere classifiedNon-preventable
N30 - CystitisNon-preventable
N30-N39 - Other diseases of the urinary systemNon-preventable
N32 - Other disorders of bladderNon-preventable
N35 - Urethral strictureNon-preventable
N359 - Urethral stricture, unspecifiedNon-preventable
N39 - Other disorders of urinary systemPreventable
N390 - Urinary tract infection, site not specifiedPreventable
N40 - Benign prostatic hyperplasiaNon-preventable
N40-N53 - Diseases of male genital organsNon-preventable
N41 - Inflammatory diseases of prostateNon-preventable
N43 - Hydrocele and spermatoceleNon-preventable
N45 - Orchitis and epididymitisNon-preventable
N47 - Disorders of prepuceNon-preventable
N471 - PhimosisNon-preventable
N48 - Other disorders of penisNon-preventable
N49 - Inflammatory disorders of male genital organs, not elsewhere classifiedNon-preventable
N60 - Benign mammary dysplasiaNon-preventable
N60-N65 - Disorders of breastNon-preventable
N61 - Inflammatory disorders of breastNon-preventable
N63 - Unspecified lump in breastNon-preventable
N70-N77 - Inflammatory diseases of female pelvic organsPreventable
N71 - Inflammatory disease of uterus, except cervixNon-preventable
N76 - Other inflammation of vagina and vulvaNon-preventable
N80 - EndometriosisNon-preventable
N80-N98 - Noninflammatory disorders of female genital tractNon-preventable
N81 - Female genital prolapseNon-preventable
N83 - Noninflammatory disorders of ovary, fallopian tube and broad ligamentNon-preventable
N83291 - Other ovarian cyst, right sideNon-preventable
N84 - Polyp of female genital tractNon-preventable
N85 - Other noninflammatory disorders of uterus, except cervixNon-preventable
N92 - Excessive, frequent and irregular menstruationPreventable
N93 - Other abnormal uterine and vaginal bleedingNon-preventable
N939 - Abnormal uterine and vaginal bleeding, unspecifiedNon-preventable
N95 - Menopausal and other perimenopausal disordersNon-preventable
N99 - Intraoperative and postprocedural complications and disorders of genitourinary system, not elsewhere classifiedNon-preventable
Nail disorders (L60)Non-preventable
Nasal polyp (J33)Non-preventable
Nausea and vomiting (R11)Non-preventable
Neoplasm of uncertain behavior of male genital organs (D40)Non-preventable
Neoplasm of uncertain behavior of oral cavity and digestive organs (D37)Non-preventable
Nephrotic syndrome (N04)Non-preventable
Neuromuscular dysfunction of bladder, not elsewhere classified (N31)Non-preventable
Neutropenia (D70)Non-preventable
Noninflammatory disorders of ovary, fallopian tube and broad ligament (N83)Non-preventable
Noninflammatory disorders of testis (N44)Non-preventable
Nonsuppurative otitis media (H65)Non-preventable
Nontraffic accident of specified type but victim's mode of transport unknown (V88)Non-preventable
Nontraumatic intracerebral hemorrhage (I61)Non-preventable
Nontraumatic subarachnoid hemorrhage (I60)Non-preventable
O00 - Ectopic pregnancyNon-preventable
Obstructive and reflux uropathy (N13)Non-preventable
Occupant of special all-terrain or other off-road motor vehicle, injured in transport accident (V86)Non-preventable
Open wound of ankle, foot and toes (S91)Non-preventable
Orchitis and epididymitis (N45)Non-preventable
Osteoarthritis of knee (M17)Preventable
Osteonecrosis (M87)Non-preventable
Osteoporosis with current pathological fracture (M80)Non-preventable
Oth aplastic anemias and other bone marrow failure syndromes (D61)Non-preventable
Other disorders of skin and subcutaneous tissue, not elsewhere classified (L98)Non-preventable
Oth symptoms and signs involving the digestive sys and abdomen (R19)Preventable
Oth transitory neonatal electrolyte and metabolic disturb (P74)Non-preventable
Other abnormal uterine and vaginal bleeding (N93)Non-preventable
Other acquired deformities of limbs (M21)Non-preventable
Other acute ischemic heart diseases (I24)Preventable
Other acute viral hepatitis (B17)Non-preventable
Other and unspecified noninfective gastroenteritis and colitis (K52)Non-preventable
Other and unspecified arthropathy (M12)Non-preventable
Other and unspecified disorders of nose and nasal sinuses (J34)Non-preventable
Other and unspecified dorsopathies, not elsewhere classified (M53)Non-preventable
Other and unspecified injuries of ankle and foot (S99)Non-preventable
Other and unspecified injuries of elbow and forearm (S59)Non-preventable
Other and unspecified injuries of head (S09)Non-preventable
Other and unspecified malignant neoplasm of skin (C44)Non-preventable
Other and unspecified nontraumatic intracranial hemorrhage (I62)Non-preventable
Other and unspecified osteoarthritis (M19)Preventable
Other arthropod-borne viral fevers, not elsewhere classified (A93)Non-preventable
Other bacterial intestinal infections (A04)Non-preventable
Other benign neoplasms of connective and other soft tissue (D21)Non-preventable
Other bursopathies (M71)Non-preventable
Other cataract (H26)Non-preventable
Other cerebrovascular diseases (I67)Non-preventable
Other chronic obstructive pulmonary disease (J44)Non-preventable
Other conduction disorders (I45)Non-preventable
Other crystal arthropathies (M11)Non-preventable
Other deforming dorsopathies (M43)Preventable
Other diseases of appendix (K38)Non-preventable
Other diseases of digestive system (K92)Non-preventable
Other diseases of gallbladder (K82)Non-preventable
Other diseases of lip and oral mucosa (K13)Non-preventable
Other diseases of liver (K76)Preventable
Other diseases of pancreas (K86)Non-preventable
Other diseases of stomach and duodenum (K31)Non-preventable
Other diseases of upper respiratory tract (J39)Non-preventable
Other disorders of arteries and arterioles (I77)Non-preventable
Other disorders of bladder (N32)Non-preventable
Other disorders of bone (M89)Non-preventable
Other disorders of brain (G93)Non-preventable
Other disorders of conjunctiva (H11)Non-preventable
Other disorders of cornea (H18)Non-preventable
Other disorders of eyelid (H02)Non-preventable
Other disorders of fluid, electrolyte and acid-base balance (E87)Non-preventable
Other disorders of lens (H27)Non-preventable
Other disorders of synovium and tendon (M67)Non-preventable
Other disorders of urinary system (N39)Preventable
Other headache syndromes (G44)Non-preventable
Other inflammatory liver diseases (K75)Preventable
Other inflammatory spondylopathies (M46)Non-preventable
Other interstitial pulmonary diseases (J84)Non-preventable
Other joint disorder, not elsewhere classified (M25)Non-preventable
Other lack of coordination (R27)Non-preventable
Other mosquito-borne viral fevers (A92)Non-preventable
Other noninflammatory disorders of cervix uteri (N88)Non-preventable
Other noninflammatory disorders of uterus, except cervix (N85)Non-preventable
Other postprocedural states (Z98)Non-preventable
Other pulmonary heart diseases (I27)Preventable
Other respiratory disorders (J98)Non-preventable
Other retinal disorders (H35)Non-preventable
Other salmonella infections (A02)Non-preventable
Other sepsis (A41)Non-preventable
Other specific joint derangements (M24)Non-preventable
Other specified diabetes mellitus (E13)Preventable
Other specified malaria (B53)Non-preventable
Other spondylopathies (M48)Non-preventable
Otitis externa (H60)Non-preventable
P91 - Other disturbances of cerebral status of newbornNon-preventable
Pain and other condition associated with female genital organs and menstrual cycle (N94)Preventable
Pain in throat and chest (R07)Preventable
Pain, not elsewhere classified (G89)Preventable
Paralytic ileus and intestinal obstruction without hernia (K56)Non-preventable
Parkinson's disease (G20)Non-preventable
Paroxysmal tachycardia (I47)Preventable
Pedestrian injured in collision with heavy transport vehicle (V04)Non-preventable
Pedestrian injured in other and unspecified transport accidents (V09)Non-preventable
Periprosthetic fracture around internal prosthetic joint (M97)Non-preventable
Peritonitis (K65)Non-preventable
Personal history of malignant neoplasm (Z85)Non-preventable
Personal history of medical treatment (Z92)Non-preventable
Personal history of other diseases and conditions (Z87)Non-preventable
Pilonidal cyst and sinus (L05)Non-preventable
Plasmodium falciparum malaria (B50)Non-preventable
Plasmodium malariae malaria (B52)Non-preventable
Plasmodium vivax malaria (B51)Non-preventable
Pleural effusion in conditions classified elsewhere (J91)Non-preventable
Pneumonia, unspecified organism (J18)Non-preventable
Pneumonitis due to solids and liquids (J69)Non-preventable
Polyosteoarthritis (M15)Preventable
Polyp of female genital tract (N84)Non-preventable
Portal vein thrombosis (I81)Non-preventable
Presence of other functional implants (Z96)Non-preventable
Purpura and other hemorrhagic conditions (D69)Non-preventable
Q40 - Other congenital malformations of upper alimentary tractNon-preventable
Q44 - Congenital malformations of gallbladder, bile ducts and liverNon-preventable
Q64 - Other congenital malformations of urinary systemNon-preventable
R00-R09 - Symptoms and signs involving the circulatory and respiratory systemsPreventable
R03 - Abnormal blood-pressure reading, without diagnosisPreventable
R04 - Hemorrhage from respiratory passagesNon-preventable
R06 - Abnormalities of breathingPreventable
R0602 - Shortness of breathNon-preventable
R07 - Pain in throat and chestPreventable
R079 - Chest pain, unspecifiedPreventable
R10 - Abdominal and pelvic painPreventable
R10-R19 - Symptoms and signs involving the digestive system and abdomenNon-preventable
R11 - Nausea and vomitingNon-preventable
R1314 - Dysphagia, pharyngoesophageal phaseNon-preventable
R19 - Other symptoms and signs involving the digestive system and abdomenPreventable
R20 - Disturbances of skin sensationNon-preventable
R20-R23 - Symptoms and signs involving the skin and subcutaneous tissueNon-preventable
R22 - Localized swelling, mass and lump of skin and subcutaneous tissueNon-preventable
R222 - Localized swelling, mass and lump, trunkNon-preventable
R29 - Other symptoms and signs involving the nervous and musculoskeletal systemsNon-preventable
R50 - Fever of other and unknown originNon-preventable
R50-R69 - General symptoms and signsNon-preventable
R5081 - Fever presenting with conditions classified elsewhereNon-preventable
R509 - Fever, unspecifiedNon-preventable
R53 - Malaise and fatiguePreventable
R56 - Convulsions, not elsewhere classifiedNon-preventable
R57 - Shock, not elsewhere classifiedNon-preventable
R60 - Edema, not elsewhere classifiedNon-preventable
R65 - Symptoms and signs specifically associated with systemic inflammation and infectionNon-preventable
R68 - Other general symptoms and signsNon-preventable
R80 - ProteinuriaNon-preventable
R80-R82 - Abnormal findings on examination of urine, without diagnosisNon-preventable
Respiratory failure, not elsewhere classified (J96)Non-preventable
Respiratory tuberculosis (A15)Non-preventable
Retention of urine (R33)Non-preventable
Retinal detachments and breaks (H33)Non-preventable
Retinal vascular occlusions (H34)Non-preventable
S00 - Superficial injury of headNon-preventable
S00-S09 - Injuries to the headNon-preventable
S00-T88 - Injury, poisoning and certain other consequences of external causesNon-preventable
S01 - Open wound of the headNon-preventable
S02 - Fracture of skull and facial bonesNon-preventable
S05 - Injury of eye and orbitNon-preventable
S06 - Intracranial injuryNon-preventable
S09 - Other and unspecified injuries of headNon-preventable
S20-S29 - Injuries to the thoraxNon-preventable
S22 - Fracture of rib(s), sternum and thoracic spineNon-preventable
S30 - Superficial injury of abdomen, lower back, pelvis and external genitalsNon-preventable
S30-S39 - Injuries to the abdomen, lower back, lumbar spine, pelvis and external genitalsNon-preventable
S31 - Open wound of abdomen, lower back, pelvis and external genitalsNon-preventable
S32 - Fracture of lumbar spine and pelvisNon-preventable
S33 - Dislocation and sprain of joints and ligaments of lumbar spine and pelvisNon-preventable
S35 - Injury of blood vessels at abdomen, lower back and pelvis levelNon-preventable
S36 - Injury of intra-abdominal organsNon-preventable
S37 - Injury of urinary and pelvic organsNon-preventable
S40-S49 - Injuries to the shoulder and upper armNon-preventable
S42 - Fracture of shoulder and upper armNon-preventable
S42201A - Unspecified fracture of upper end of right humerus, initial encounter for closed fractureNon-preventable
S43 - Dislocation and sprain of joints and ligaments of shoulder girdleNon-preventable
S46 - Injury of muscle, fascia and tendon at shoulder and upper arm levelNon-preventable
S4601 - Strain of muscle(s) and tendon(s) of the rotator cuff of shoulderNon-preventable
S49 - Other and unspecified injuries of shoulder and upper armNon-preventable
S50-S59 - Injuries to the elbow and forearmNon-preventable
S52 - Fracture of forearmNon-preventable
S525 - Fracture of lower end of radiusNon-preventable
S53 - Dislocation and sprain of joints and ligaments of elbowNon-preventable
S59 - Other and unspecified injuries of elbow and forearmNon-preventable
S60 - Superficial injury of wrist, hand and fingersNon-preventable
S60-S69 - Injuries to the wrist, hand and fingersNon-preventable
S61 - Open wound of wrist, hand and fingersNon-preventable
S62 - Fracture at wrist and hand levelNon-preventable
S63 - Dislocation and sprain of joints and ligaments at wrist and hand levelNon-preventable
S67 - Crushing injury of wrist, hand and fingersNon-preventable
S69 - Other and unspecified injuries of wrist, hand and finger(s)Non-preventable
S70-S79 - Injuries to the hip and thighNon-preventable
S72 - Fracture of femurNon-preventable
S729 - Unspecified fracture of femurNon-preventable
S7291 - Unspecified fracture of right femurNon-preventable
S73 - Dislocation and sprain of joint and ligaments of hipNon-preventable
S80 - Superficial injury of knee and lower legNon-preventable
S80-S89 - Injuries to the knee and lower legNon-preventable
S82 - Fracture of lower leg, including ankleNon-preventable
S8212 - Fracture of lateral condyle of tibiaNon-preventable
S83 - Dislocation and sprain of joints and ligaments of kneeNon-preventable
S8353 - Sprain of cruciate ligament of kneeNon-preventable
S86 - Injury of muscle, fascia and tendon at lower leg levelNon-preventable
S90 - Superficial injury of ankle, foot and toesNon-preventable
S90-S99 - Injuries to the ankle and footNon-preventable
S91 - Open wound of ankle, foot and toesNon-preventable
S92 - Fracture of foot and toe, except ankleNon-preventable
S93 - Dislocation and sprain of joints and ligaments at ankle, foot and toe levelNon-preventable
S97 - Crushing injury of ankle and footNon-preventable
S999 - Unspecified injury of ankle and footNon-preventable
Secondary hypertension (I15)Preventable
Sequelae of cerebrovascular disease (I69)Preventable
Sleep disorders (G47)Preventable
Spondylosis (M47)Preventable
Spontaneous rupture of synovium and tendon (M66)Non-preventable
Spotted fever [tick-borne rickettsioses] (A77)Non-preventable
STEMI & NSTEMI myocardial infarction (I21)Preventable
Stomatitis and related lesions (K12)Non-preventable
Superficial injury of ankle, foot and toes (S90)Non-preventable
Superficial injury of head (S00)Non-preventable
Superficial injury of wrist, hand and fingers (S60)Non-preventable
Suppurative and unspecified otitis media (H66)Non-preventable
Syncope and collapse (R55)Non-preventable
Synovitis and tenosynovitis (M65)Non-preventable
Systemic disorders of connective tissue in diseases classified elsewhere (M36)Non-preventable
T23 - Burn and corrosion of wrist and handNon-preventable
T34 - Frostbite with tissue necrosisNon-preventable
T43 - Poisoning by, adverse effect of and underdosing of psychotropic drugs, not elsewhere classifiedNon-preventable
T44 - Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous systemNon-preventable
T66-T78 - Other and unspecified effects of external causesNon-preventable
T670 - Heatstroke and sunstrokePreventable
T78 - Adverse effects, not elsewhere classifiedNon-preventable
T80-T88 - Complications of surgical and medical care, not elsewhere classifiedNon-preventable
T81 - Complications of procedures, not elsewhere classifiedNon-preventable
T814 - Infection following a procedureNon-preventable
T814XXA - Infection following a procedure, initial encounterNon-preventable
T82 - Complications of cardiac and vascular prosthetic devices, implants and graftsNon-preventable
T83 - Complications of genitourinary prosthetic devices, implants and graftsNon-preventable
T84 - Complications of internal orthopedic prosthetic devices, implants and graftsNon-preventable
T86838 - Other complications of bone graftNon-preventable
Thoracic, thoracolumbar, and lumbosacral intervertebral disc disorders (M51)Non-preventable
Thyroiditis (E06)Non-preventable
Toxic effect of contact with venomous animals and plants (T63)Non-preventable
Transplanted organ and tissue status (Z94)Non-preventable
Traumatic amputation of elbow and forearm (S58)Non-preventable
Tuberculosis of other organs (A18)Non-preventable
Type 2 diabetes mellitus (E11)Preventable
Typhoid and paratyphoid fevers (A01)Non-preventable
U04 - Severe acute respiratory syndrome [SARS]Non-preventable
U07 - Emergency use of U07Non-preventable
U07 - Infections due to SARS-CoV-2Non-preventable
Ulcerative colitis (K51)Non-preventable
Umbilical hernia (K42)Non-preventable
Unspecified abdominal hernia (K46)Non-preventable
Unspecified acute lower respiratory infection (J22)Non-preventable
Unspecified appendicitis (K37)Non-preventable
Unspecified arthropod-borne viral fever (A94)Non-preventable
Unspecified jaundice (R17)Non-preventable
Unspecified malaria (B54)Non-preventable
Unspecified maternal hypertension (O16)Preventable
Unspecified renal colic (N23)Non-preventable
Unspecified viral hemorrhagic fever (A99)Non-preventable
Unspecified viral hepatitis (B19)Non-preventable
Urethral stricture (N35)Non-preventable
Urethritis and urethral syndrome (N34)Non-preventable
V00-Y99 - External causes of morbidityNon-preventable
V01 - Pedestrian injured in collision with pedal cycleNon-preventable
V80-V89 - Other land transport accidentsNon-preventable
V86 - Occupant of special all-terrain or other off-road motor vehicle, injured in transport accidentNon-preventable
V89 - Motor- or nonmotor-vehicle accident, type of vehicle unspecifiedNon-preventable
Varicose veins of lower extremities (I83)Preventable
Vascular syndromes of brain in cerebrovascular diseases (G46)Preventable
Ventral hernia (K43)Non-preventable
Viral agents as the cause of diseases classified elsewhere (B97)Non-preventable
Viral and other specified intestinal infections (A08)Non-preventable
Viral infection of unspecified site (B34)Non-preventable
Viral pneumonia, not elsewhere classified (J12)Non-preventable
Vitamin B12 deficiency anemia (D51)Preventable
W00-W19 - Slipping, tripping, stumbling and fallsNon-preventable
W01 - Fall on same level from slipping, tripping and stumblingNon-preventable
w25 - Contact with sharp glass, initial encounterNon-preventable
W50-W64 - Exposure to animate mechanical forcesNon-preventable
Whooping cough (A37)Non-preventable
Y04 - Assault by bodily forceNon-preventable
Z03.8 - Medical observation and evaluation for suspected diseases and conditionsNon-preventable
Z20 - Contact with and exposure to communicable diseasesNon-preventable
Z30 - Encounter for contraceptive managementPreventable
Z40-Z53 - Encounters for other specific health careNon-preventable
Z41 - Encounter for procedures for purposes other than remedying health stateNon-preventable
Z45 - Encounter for adjustment and management of implanted deviceNon-preventable
Z4582 - Encounter for adjustment or removal of myringotomy device (stent) (tube)Non-preventable
Z46 - Encounter for fitting and adjustment of other devicesNon-preventable
Z47 - Orthopedic aftercareNon-preventable
Z48 - Encounter for other postprocedural aftercareNon-preventable
Z51 - Encounter for other aftercare and medical careNon-preventable
Z77-Z99 - Persons with potential health hazards related to family and personal history and certain conditions influencing health statusPreventable
Z80 - Family history of primary malignant neoplasmNon-preventable
Z83 - Family history of other specific disordersNon-preventable
Z85 - Personal history of malignant neoplasmNon-preventable
Z8673 - Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficitsPreventable
Z87 - Personal history of other diseases and conditionsNon-preventable
Z90 - Acquired absence of organs, not elsewhere classifiedNon-preventable
Z92 - Personal history of medical treatmentNon-preventable
Z94 - Transplanted organ and tissue statusNon-preventable
Z95 - Presence of cardiac and vascular implants and graftsPreventable
Z96 - Presence of other functional implantsNon-preventable
Z960 - Presence of urogenital implantsNon-preventable
Z96621 - Presence of right artificial elbow jointNon-preventable
Z9664 - Presence of artificial hip jointNon-preventable
Z98 - Other postprocedural statesPreventable
Z99 - Dependence on enabling machines and devices, not elsewhere classifiedNon-preventable
Zygomycosis (B46)Non-preventable

Disclosures

Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study.

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: This work was conducted jointly by Aditya Birla Health Insurance and Zyla Health, who have a business (client–vendor) relationship. One of the authors, Dr Kapil Verma, PhD, provided consulting services to Zyla Health for this study. The authors declare no other conflicts of interest.

Author Contributions

Acquisition, analysis, or interpretation of data: Kapil Verma, Khushboo Aggarwal

Drafting of the manuscript: Kapil Verma, Khushboo Aggarwal

Critical review of the manuscript for important intellectual content: Kapil Verma, Gouri Karajgi, Rajesh Patidar

Concept and design: Gouri Karajgi, Rajesh Patidar, Khushboo Aggarwal

References

1. Cardiovascular diseases in India: current epidemiology and future directions. Prabhakaran D, Jeemon P, Roy A. Circulation. 2016;133:1605–1620. doi: 10.1161/CIRCULATIONAHA.114.008729.

2. Cost of hospitalisation for non-communicable diseases in India: are we pro-poor? Tripathy JP, Prasad BM, Shewade HD, et al. https://www.researchgate.net/profile/Jaya-Tripathy/publication/313215851_Prioritised_Research_Agenda_for_NCDs/links/5892be4e458515aeac946479/Prioritised-Research-Agenda-for-NCDs.pdf . Trop Med Int Health. 2016;21:1019–1028. doi: 10.1111/tmi.12732.

3. A study of catastrophic health expenditures in India-evidence from nationally representative survey data: 2014-2018. Sriram S, Albadrani M. F1000Res. 2022;11:141. doi: 10.12688/f1000research.75808.1.

4. Wellness programs offered by the health insurance companies. Rangayyan M, Kapadia D. Int J Prev Med. 2024;4:6–11.

5. A systematic review of the literature on health and wellness coaching: defining a key behavioral intervention in healthcare. Wolever RQ, Simmons LA, Sforzo GA, et al. Glob Adv Health Med. 2013;2:38–57. doi: 10.7453/gahmj.2013.042.

6. Supporting sustainable health behavior change: the whole is greater than the sum of its parts. Matthews JA, Matthews S, Faries MD, Wolever RQ. Mayo Clin Proc Innov Qual Outcomes. 2024;8:263–275. doi: 10.1016/j.mayocpiqo.2023.10.002.

7. Impacts of chronic disease prevention programs implemented by private health insurers: a systematic review. Wanni Arachchige Dona S, Angeles MR, Hall N, Watts JJ, Peeters A, Hensher M. BMC Health Serv Res. 2021;21:1222. doi: 10.1186/s12913-021-07212-7.

8. Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: trial-based analysis of the Kerala Diabetes Prevention Program. Sathish T, Oldenburg B, Thankappan KR, et al. BMC Med. 2020;18:251. doi: 10.1186/s12916-020-01704-9.

9. The Ayushman Bharat Digital Mission of India: an assessment. Mishra US, Yadav S, Joe W. Health Syst Reform. 2024;10:2392290. doi: 10.1080/23288604.2024.2392290.

10. Computational tools for probing interactions in multiple linear regression, multilevel modeling, and latent curve analysis. Preacher KJ, Curran PJ, Bauer DJ. J Educ Behav Stat. 2006;31:437–448.

11. Transforming mental health systems globally: principles and policy recommendations. Patel V, Saxena S, Lund C, et al. Lancet. 2023;402:656–666. doi: 10.1016/S0140-6736(23)00918-2.

12. Factors predicting engagement of older adults with a coach-supported eHealth intervention promoting lifestyle change and associations between engagement and changes in cardiovascular and dementia risk: secondary analysis of an 18-month multinational randomized controlled trial. Coley N, Andre L, Hoevenaar-Blom MP, et al. J Med Internet Res. 2022;24:0. doi: 10.2196/32006.

13. Catastrophic health spending among older adults in India: role of multiple deprivation. Panda BK, Mohanty SK. Aging Health Res. 2022;2:100100.

14. Heard and valued: the development of a model to meaningfully engage marginalized populations in health services planning. Snow ME, Tweedie K, Pederson A. BMC Health Serv Res. 2018;18:181. doi: 10.1186/s12913-018-2969-1.

15. Factors that influence older patients' participation in clinical communication within developed country hospitals and GP clinics: a systematic review of current literature. Gaffney HJ, Hamiduzzaman M. PLoS One. 2022;17:0. doi: 10.1371/journal.pone.0269840.

16. Consequences of India's population aging to its healthcare financing and provision. Sahoo PM, Rout HS, Jakovljevic M. J Med Econ. 2023;26:308–315. doi: 10.1080/13696998.2023.2178164.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты